Tumour growth is a multifactorial process, which has stimulated in recent decades the development of numerous models trying to figure out the mechanisms controlling solid tumours morphogenesis. While the earliest models were focusing on cell proliferation kinetics, modulated by the availability of supplied nutrients, new modelling approaches emphasize the crucial role of several biophysical processes, including local matrix remodelling, active cell migration and traction, and reshaping of host tissue vasculature. After a brief presentation of this experimental background, this review will outline a number of representative models describing, at different scales, the growth of avascular and vascularized tumours. Special attention will be paid to the formulation of tumour-host tissue interactions that selectively drive changes in tumour size and morphology, and which are notably mediated by the mechanical status and elasticity of the tumour microenvironment. Emergence of invasive behaviour through growth instabilities at the tumour-host interface will be presented considering both reaction-diffusion and mechano-cellular models. In the latter part of the review, patient-oriented implications of tumour growth modelling are outlined in the context of brain tumours. Some conceptual views of the adaptive strategies and selective barriers that govern tumour evolution are presented in conclusion as potential guidelines for the development of future models.
Introduction
Tumorigenesis, i.e. the process of initiation and progression of a tumour, is a multifactorial process, surely emerging from molecular and genetic abnormalities (Albertson et al 2003 , Balmain et al 2003 , but also strongly dependent on cell-cell and cell-extracellular matrix (ECM) macroscopic regulations and interactions (Bissell et al 2002 , Ruiter et al 2002 , Vincent and Gatenby 2008 . It is known that a tumour (from the Latin verb tumere, meaning to bulge or to swell) originates from the transformation of normal cells into cancer cells (carcinogenesis), which acquire the ability to become unresponsive to normal physiological controls . But this simple statement embraces the extremely diverse and complex reciprocal dialogues that cells and molecules comprising a tumour engage through highly regulated interactions favouring malignancy.
In the past 25 years, a majority of cancer studies have focused on examining functional consequences of activating and/or inactivating mutations in critical genes implicated in cell cycle control. These studies have taught us a great deal about the functions of tumour promoter genes (oncogenes) and tumour suppressor genes, as well as on the signalling pathways regulating cell proliferation and cell death (apoptosis). However, such studies have often ignored the fact that cancers are heterogeneous cellular entities whose growth is dependent upon reciprocal and dynamical interactions between genetically altered cells and the timevarying microenvironment in which they live. Especially, and in view of further modelling approaches, it is worth underlining that pathological features observed during cancer progression are still close enough to crucial physiological processes. Indeed, these series of multistage events involving cellular and tissular mutual influences also orchestrate organ morphogenesis during embryonic development and tissue repair occurring in wound healing. Thus, tumour growth is often presented as a 'wound that does not heal' , Chang et al 2004 , Dvorak 1986 , Kalluri and Zeisberg 2006 , illustrating the paradoxical aspects of tumorigenesis and the subtle transition existing between physiological and pathological contexts. Thus, stromas, i.e. the arrangement of cells and connective tissue at sites of wound healing and tumour growth, share many characteristics (Chang et al 2004 , Dvorak 1986 ). Other biological processes, including cell migration, tissue remodelling and formation of new vasculature, which are crucial and normal features utilized during tissues repairing and healing, are also critically regulated events in growing tumours (Tlsty and Coussens 2006) .
Thus, while cancer is still currently viewed as a disease involving irreversible genomic changes affecting intrinsic cellular programs, one has to consider that such genomic alterations act in combination with modifications of extrinsic programs taking place in environmental conditions defined by inflammation, immune response, matrix metabolism and stiffness, gradients of signalling molecules, tissue oxygenation and vascular status, which all combine and underline tumour development (Kassis et al 2001 , Lunt et al 2008 . In the case of solid tumours, which are considered in this paper, these interactions include signalling through cell adhesion molecules, such as cadherins and integrins (Hynes 2002a) , and host tissue remodelling through the action of enzymes, such as plasmin or metalloproteinases (Egeblad and Werb 2002) , as well as differential cell response to growth factors and signalling molecules (Balkwill 2004 , Coussens and Werb 2002 , Kulbe et al 2004 , all of which act together to control processes such as proliferation, survival/apoptosis, migration and invasion. Recent research in cell and tumour biology notably highlighted that a wide range of cellular and molecular processes are tightly controlled by mechanical factors depending on cell cytoskeleton and ECM mechanical properties (Butcher et al 2009 , Tilghman and Parsons 2008 , Zaman et al 2006 . It is of particular interest that the expression of many of the genes involved in biological processes quoted above can be affected by both the biochemical and biophysical conditions defining the tumour microenvironment, including hypoxia and mechanical stresses , Liotta and Kohn 2001 , Lunt et al 2008 , Scheurer et al 2004 .
In this context, modelling of tumour growth is a rather old research subject (Araujo and McElwain, 2004, Byrne et al 2006) , but which neither stops getting increasing relevance because of the challenge arising from considering (i) on the one hand the exponential accumulation of data produced by the development of new techniques from molecular biology within all components of the 'omics' family, from genomics, epigenomics and proteomics to metabolomics Baylin 2007, Nielsen and Oliver 2005) (ii) on the other hand, the necessity of conducting models development in an integrative or system biology framework in order to counterbalance the limitation of reductionist approaches relying only on molecular biology studies, since they are insufficient to tackle systemic aspects of tumour development (Anderson and Quaranta 2008 , Bissell et al 2005 , Bizzarri et al 2008 , Ingber 2002 .
Early models of tumour growth were based on kinetic models of cell proliferation, and then mostly investigated from a mathematical point of view (Araujo and McElwain 2004) . However, an evolution toward a more physical approach of tumour growth has taken place in the last ten years (Preziosi 2003) . Notably, theoretical models have been improved by increasing consideration of (i) the biomechanics of the tumour and its microenvironment, (ii) the coupling of tumour growth with the tumour vascularization process, i.e. tumour angiogenesis (Chaplain et al 2006 , Roose et al 2007 . The evolution of tumour growth models has concomitantly coped with the complexity and non-intuitive end products originating from multifactorial and mostly nonlinear biological processes, which require the development and renewal of concepts in this field (Gatenby and Maini 2002 , Nagy 2005 , Potter 2001 , Quaranta et al 2008 , Vincent and Gatenby 2008 .
It is known that one obstacle that biophysical models of living systems must overcome is the multiplicity of the time and length scales, from molecular and intra-cellular processes (e.g. progression through the cell cycle, signal transduction, etc) to tissular processes, especially microenvironment remodelling and vascularization. At a microscopic scale, tumour models would suitably describe malignant transformation of normal cells and associated alterations of cell-cell interactions and tumour heterogeneity. At a macroscopic scale, models must consider cell response to gradient fields of diverse origins, such as concentration gradients of diffusible or non-diffusible molecules as well as strain and stress gradients generated by the growing tumour mass. Thus, one might at least expect that biophysical models of tumour growth will be able to (i) cope with physical phenomena that differ in nature but are still highly connected, (ii) gather in a manageable way the most relevant data provided by multimodal tumour imaging and by biophysical measurements of tumour and tumourmicroenvironment properties, (iii) provide explanations and predictions helpful for the design and optimization of therapies targeting tumour development.
Before considering more precisely the set of a priori relevant data in this modelling perspective, it seems worth starting with simple outlines that may shed light on the progressive evolution of the models reviewed in this paper. One should first observe that the growth of solid tumours is physically a mechanical process according to which a heterogeneous tissue expands within a surrounding medium. Expansion is controlled by some internal driving stresses, which are counterbalanced by the mechanical resistance provided by the surrounding tumour environment (figure 1). As a first implication, the interface of the tumour and its environment appears as a region of remarkable interest since complex phenomena could develop there, especially through instabilities which may break a uniform and compact tumour front into the wavy and irregular morphologies that can be observed experimentally, and which dramatically correlate with increased tumour aggressiveness (Weigelt and Bissell 2008) .
A second modelling guideline is the recognition of the biological specificity of the tumour growth, which is driven by both physical and active cellular processes. Typically, internal stresses are mostly generated by cell proliferation dynamics, influenced by the diffusion of nutrients within the tumour. Similarly, the physical forces existing at the tumour front are not just force balance equations involving tumour surface tension and the resistive pressure of the surrounding medium. Active cellular traction forces mediate cell adhesion and migration in this interface region (figure 1) (Gordon et al 2003 , Mierke et al 2008 . These mechanical forces reshape the tumour microenvironment, either directly by structural changes enforcing medium anisotropy, or indirectly by activating mechanosensitive cellular processes (Butcher Notably, all processes contribute to the modulation of the mechanical stresses within the tissue, stroma and tumour. Arrows highlight that both normal and tumour cells dynamically adapt to such stresses and strains by modifying their behaviour and remodelling their microenvironment. Thus, the indicated circular feedback loop might increase ECM compaction and density around the tumour (encapsulation) or conversly contribute to tumour cell detachment and disease progression.
et al 2009, , Olson and Sahai 2009 . A third element underlying this schematic modelling framework of solid tumour growth is the recognition of the rather large range of physical properties exhibited by the biological objects themselves, i.e. the diversity and specificity of the biomechanical properties of individual cells (Suresh 2007) , of tumours (Netti et al 2000 , Venkatesh et al 2008 , and of the tumour microenvironment and host tissue (Humphrey 2003) . Therefore, a rather large spectrum of mechanical and biological responses to endogenous and exogenous stimuli has to be expected. Keeping in mind these introductory remarks, this paper reviews some of the representative contributions to the modelling of solid tumour growth. We will focus mainly on continuous approaches, extended to some recent hybrid continuous-discrete models coupling physical processes to cellular automaton or multiagent-based description of cell behaviour. Owing to the enormous body of journals and publications devoted to the analysis of solid tumour growth, no such review could be comprehensive. Nevertheless, we tried to provide a concise overview, illustrating from selected representative papers and contributions of research groups how the field of tumour growth modelling has evolved from earlier mathematical description to recent models more firmly grounded on the physical and mechanical aspects sketched above. Thus, special attention will be given to most recent studies and their capacity to account for extended sets of in vitro and in vivo data, while underlying the continuity or breakthrough with regard to earlier models. The main issues, orientations and perspectives will be highlighted without going into the details of the models formulation, which can be found exhaustively in the corresponding quoted references.
The outline of the paper is as follows: in the continuity of this introductory part, section 2 reviews the main components of the increasing corpus of biological processes and data that have supported and inspired the evolution of tumour growth models, from earlier studies to more recent works. Section 3 presents the leading aspects of these earliest models, largely devoted to the study of avascular solid tumour growth and which assign to the diffusion of nutrients a critical role in determining tumour architecture and growth rate. Recent extensions of avascular tumour models, taking into account more explicitly the influence of the mechanical resistance introduced by the tumour microenvironment, are presented in section 4. Modelling of the dynamics at the tumour-host tissue interface is developed in section 5, emphasizing the prominent role of the morphological instabilities that may be generated at the tumour front beyond some bifurcation threshold. Section 6 extends this analysis by considering architectural modification of the tumour environment due to tumour angiogenesis. The development of a vascular network within the tumour vascularization is a multiscale problem that is presented in section 7, in association with a review of hybrid models of tumour growth. Tumour growth models are developed with the hope of being able to predict and optimize tumour response to treatment. These aspects are reviewed in section 8, where the evolution of tumours in conjunction with different therapies is illustrated in the case of brain tumours. Conclusions and perspectives will be addressed in the final section, focusing on (i) the ability of biophysical models to deal with alterations of cell and tissue dynamical architecture that characterize the first critical stages of tumour development, (ii) some conceptual evolutions which might stimulate new modelling strategies and (iii) the models clinical value for improvement and new design of therapeutic strategies against malignancy.
Biological background underlying tumour growth modelling: a brief overview
This section reviews some key biological processes and experimental data, which give consistence to relevant modelling of tumour growth. Without going into excessive detail, the challenge is to provide a concrete background and critical arguments to evaluate the relevance, benefits and limitations of the models that will be presented in the following sections.
Tumour growth as a deregulation of the interplay between intrinsic cellular programs and environmental constraints
Let us recall that solid tumours are heterogeneous multicellular entities containing a diverse population of cells, composed of genetically mutated cancer cells as well as other cell types present in the tumour microenvironment, including fibroblasts, immune cells and cells lining blood vessels. These cells are embedded in irregular tissue architecture exhibiting an abnormal microcirculation, with a loss of vascular hierarchy and large variability in vessel diameter, length and tortuousness.
Since cancer is still largely considered as a genetic disease rather than as a system biology disease (Bizzarri et al 2008) , much research has focused on genetic and molecular properties of the tumour cells themselves. Nevertheless, such genomic alterations act in concert with several biological and biophysical processes, which modify local tissue homeostasis by stimulating cell proliferation, motility and differentiation, while simultaneously impairing cell death (apoptosis), cell adhesion and microenvironment architecture (Kass et al 2007) . Thus, hypoxic microenvironment of a tumour modifies the expression of a number of genes contributing to cancer cells survival and growth, and to metastatic efficiency (Keith and Simon 2007 , Scheurer et al 2004 . Tissue vascularization, immune response and ECM turnover depend on reciprocal interactions between normal and cancer cells, between cells and soluble molecules, and between cells and ECM (Tlsty and Coussens 2006, Weigelt and Bissell 2008) . The mechanical stresses experienced by tumour cells and tumour stroma may equally affect cell phenotype and the expression of several genes through mechanotransduction processes (Butcher et al 2009 , Liotta and Kohn 2001 , Lunt et al 2008 , Scheurer et al 2004 , as further detailed in section 2.3. Globally, solid tumour growth cannot be sustained unless the tumour efficiently co-opts inflammatory cells, vascular cells and fibroblasts to help reset the balance between ECM degradation and ECM biosynthesis (Bhowmick et al 2004 , Coussens and Werb 2002 , Tlsty 2001 .
Fibroblasts, the predominant cells in the ECM (Bosman and Stamenkovic 2003) , were thought to be passive participants in neoplastic programming of tissues. However, recent data indicate that they exert an active role: they are able to develop significant mechanical forces (Gutierrez-Fernandez et al 2008 , Tymchenko et al 2007 and are responsible for the production of various classes of proteolytic enzymes, their inhibitors, as well as many soluble paracrine growth factors that regulate cell proliferation, morphology, survival and death (Kalluri and Zeisberg 2006 , Sugimoto et al 2006 , Zeisberg et al 2007 . In response to pathologic signals, fibroblasts change their phenotype and function and undergo dynamic changes accompanying tumour progression (Zeisberg et al 2007) . While multiple cell types contribute to the maintenance of appropriate ECM composition at the invasive front, similar to that observed during wound healing, fibroblasts and vascular cells are particularly responsible for the new synthesis and remodelling of ECM components (collagens, fibronectin, etc) that commonly surround solid tumours.
It is intuitively clear that inappropriate synthesis or degradation of any ECM molecule can alter the architecture and the mechanical state of the stroma and tumour microenvironment, thus modifying host tissue integrity. Indeed, the turnover of ECM molecules-synthesis balanced by degradation-is essential for maintaining tissue homeostasis (Wolf et al 2007) . When developing neoplasms undergo malignant conversion and acquire the capacity to invade normal tissue, increased architectural disorder at the invasive front of the neoplastic mass is characteristic, with the balance between ECM synthesis and degradation shifted in favour of ECM accumulation or fibrosis. Accordingly, composition and architecture of ECM varies considerably during tumorigenesis and the newly synthesized peri-tumoral stroma is mostly characterized by a disorganized orientation of the collagen fibres (Ruiter et al 2002) . Importantly, such increased collagen synthesis and dense accumulation of fibrillar collagens result in tight encapsulation of malignant cells that creates a physical barrier to tumour expansion (Kass et al 2007) .
This deregulation toward increased synthesis of extracellular components is more or less counterbalanced by enzymatic degradation (proteolysis) of pericellular ECM molecules in the tumour neighbourhood, predominantly by matrix metalloproteinases (MMPs). This large family of proteolytic enzymes, which normally remodel ECM, are secreted by epithelial cells, activated fibroblasts and inflammatory cells (Coussens et al 2002 , Egeblad and Werb 2002 , Sternlicht and Werb 2001 . These enzymes are either soluble or plasma membraneassociated and play key roles in wound healing and in cancer progression (Egeblad and Werb 2002) . Interestingly, these enzymes regulate tumour development in several ways: they were originally described as cleaving ECM substrates, but several recent studies indicate they could also have a surprising and counterintuitive protective role (Gutierrez-Fernandez et al 2008) . As in many enzymatic networks, specific inhibitors control MMPs activity, namely the tissue inhibitors of metalloproteinases (TIMPs) (Lafleur et al 2003) . Globally, the expression of many MMPs and TIMPs, and thus ECM remodelling, is regulated at the transcription level by a variety of growth factors, cytokines and chemokines, but also at a posttranscriptional level in specific cases (Clark et al 2008 , Fu et al 2008 . Thus, tumour growth takes place in a highly dynamic landscape that develops a multifactorial environmental response to tumour development.
Contribution of active biophysical processes to tumour growth: cell migration and cellular forces
Tumour cells migration is obviously a determinant process favouring solid tumour expansion. Let us recall that cell migration involves a series of highly coordinated events, including the extension of cell membrane protrusions, the formation of new adhesions, the development of traction forces and the release of previous adhesion to ensure cell body translocation (Sheetz et al 1998 (Sheetz et al , 1999 . In the context of cancer cell migration, special attention has been paid to thin actin-rich protrusions, termed invadopodia, that colocalize high proteolytic activity and cytoskeletal signalling pathways to cell-ECM contact points.
All these processes received increasing attention from the biologists and physicists. Thus, observations of the nanodynamics of invadopodium by atomic force microscopy revealed the remarkable directionality of this cell projection and its sensitivity to cell-cell biochemical signalling . Since the pioneering work of Harris et al more than two decades ago imaging the wrinkling of thin elastic substrates by adherent cells (Harris et al 1981 (Harris et al , 1984 , analysis of cellular traction forces fosters the development of a remarkable diversity of experiments. Indeed, even non-muscle cells, like endothelial cells (ECs) or fibroblasts, remarkably generate active tension through an actomyosin filament sliding mechanism similar to the one used in the contraction of smooth muscles cells. Importantly, both normal and cancer cells exert traction forces onto their own environment (du Roure et al 2005) . The qualitative and quantitative features of cell traction forces exerted by different types of cells, including tumour cells, are now rather well documented (Delvoye et al 1991 , Dembo et al 1996 , Shreiber et al 2003 , thanks to the large spectrum of experimental setups developed at different scales. This spectrum includes measurements of isometric tension or compaction rates of viscoelastic biogels contracted by cellular forces (Benkherourou et al 2000 , Eastwood et al 1996 , Kolodney and Wysolmerski 1992 , as well as the tracking of microbeads displacements and of the deformations of substrates with printed micro-lithography patterns (Balaban et al 2001 , Beningo et al 2002 , Oliver et al 1999 . More recently, several micro and nanotechnology devices, designed as discrete deflectable elements such as micro-cantilevers (Galbraith and Sheetz 1997) In addition to random migration, it is known that cells can exhibit directional migration, or taxis, in response to environmental gradients of both soluble chemicals (chemotaxis) and substrate-attached molecules (haptotaxis) , Lamalice et al 2007 , Lecaudey and Gilmour 2006 , Weiner 2002 ). In addition, it has been shown more recently that ECM mechanical properties also influence cell migration (mechanotaxis) (Kass et al 2007 , Zaman et al 2006 . Importantly, cells are able to discriminate between soft and rigid ECM (Alexander et al 2008) , then developing a net cell motion in the direction of higher ECM rigidity (Zaman et al 2006) , a phenomenon known as durotaxis (Lo et al 2000) . Furthermore, architectural properties of ECM are of critical importance for directional cell migration. Indeed, cellular shape, orientation, adhesion and migration can be guided by the topography of the microenvironment (figure 2). Such topographic guidance of cell migration has been evidenced by the alignment of cells migrating on micro-machined grooves in the substrate or on micropillars (Saez et al 2007 , TzvetkovaChevolleau et al 2008 .
Taken together, these few experimental findings indicate that many possible regulatory loops may differentially affect the dynamics of normal and cancer cells, and thus the expansion of a solid tumour. For example, cellular forces may induce the re-organization of the tumour microenvironment from a diffuse quasi-isotropic to an anisotropic fibrillar ECM assembly, thus modifying ECM and stroma architecture, and thus exerting feedback onto cell migration and associated tumour growth (Spencer et al 2007) .
In this case, mechanosensing processes have a leading role in the determination of the cellular response.
Transduction of physical signals
Transduction of physical signals is known to regulate a large array of physiological processes, from hearing and touch to bone and vasculature shaping (Jaalouk and Lammerding 2009) . Therefore, it is not surprising that failure of mechanosensitive processes contributes to cancer if tumour cells, already stimulated by various chemical signals, additionally sense and respond to the mechanical cues provided by mechanical interactions with their extracellular environment (Bissell et al 2002 , Sottile 2004 ). More precisely, it appears clearly that ECM provides not only the necessary structural support for cell migration as presented previously, but is also part of the deformable continuum able to transmit signals through cellsurface adhesion sites (Chen 2008 . Such adhesion regions correspond to different clusters of proteins, ranging from dot-like adhesion to larger focal adhesions (Hirata et al 2008) . Cell adhesion at these sites is accompanied by a remodelling of the cytoskeleton network into densely packed straight fibres made of actin filaments. Specific transmembrane receptors like integrins, a large family of heterodimers which differ by the combination of their two subunits (α, β) (Hynes 2002b) , ensure a physical continuity and dynamic links between extracellular environment on one side of the plasmic membrane and the complex molecular bridges that connect the cytoskeleton actin filaments to the cytoplasmic domains of integrin subunits on the other side (figure 3) (Berrier and Yamada 2007, Gieni and Hendzel 2008) . These scaffolds define a multi-component mechanosensory switch (figure 4) through which control and adaptation of cell response to mechanical stresses and strains will operate (Chen 2008 , Geiger and Bershadsky 2002 , Wang et al 2007 .
Thus, cellular tension drives cell adhesion and focal adhesions assembly, growth and maintenance depend on mechanical forces applied to them (Smith et al 2008) . Such adaptive behaviour was investigated using extracellular substrates of different mechanical stiffness, with studies reporting that cells organize their cytoskeleton and adhesive contacts differently on soft and stiff surfaces (Alexander et al 2008 , Collin et al 2006 . In the light of the proposed mechanosensory switch behaviour, the tension acting on the adhesion sites of cells attached to a flexible substrate may be smaller than when cells are spread over a rigid surface. Consequently, dimensions of focal adhesions formed on soft elastic substrates are smaller than those formed when cells are attached on a stiffer ECM (Balaban et al 2001 , Riveline et al 2001 .
According to these experimental data, the interplay between mechanical forces and tissue growth and remodelling appears as a central process in the modelling of tumour growth, with mechanotransduction, i.e. the conversion of mechanical force into biochemical information (Huang et al 2004 , Orr et al 2006 , being a key function for understanding how tumour cells and tumour growth are affected by mechanical constraints. Since this structural continuity is ensured up to the cell nucleus and the nuclear matrix (Wang et al 2009) , the tensional state of ECM and tumour stroma may influence cell dynamics by modifying cellular phenotypes and expression of mechanosensitive genes (Gieni and Hendzel 2008 , Orr et al 2006 , Wang et al 2007 . The ECM and tumour mechanical status depends on several factors, originating from intracellular contractile machinery, from external loads due to mechanical activity of neighbouring, from resistive stresses exerted by the host tissue on the growing tumour as well as from movement of fluids within tumour interstitium (Netti et al 2000) . The balance of internal and external stresses at a mechanosensor, like focal adhesion, drives the tensional homeostasis experienced by the cell and the subsequent up or down regulation of fundamental cellular functions such as proliferation, adhesion, migration or differentiation. The stress balance depends on both active elements (intracellular contraction or traction exerted by neighbouring cells) and passive components (cystoskeleton and ECM stiffnesses). Then, softening or hardening, i.e. remodelling of these viscoelastic components, directly affects the local tensional homeostasis.
These considerations underline that the development and relevance of biophysical models of tumours have to be examined in the light of different concepts. A first one is the dynamic reciprocity concept proposed by Bissel and co-workers Aggeler 1987, Nelson and Bissell 2006) to qualify the mutual interactions of cells and their environment through bi-directional (outside-in/inside-out) signalling feedback schemes. As a mechanical extension of the homeostasis concept, a cornerstone of physiological regulations, the tensional homeostasis concept, and its deregulation in cancer, was invoked more recently as a relevant background for analysing tumour growth (Butcher et al 2009 , Paszek et al 2005 . Both concepts are linked, the latter one qualifying how the tumour microenvironment specifies a contextual information framework for both normal and cancer cells to determine the correct (or incorrect) response to superimposed biochemical and biomechanical stimuli (figure 4). Dynamic reciprocity usually involves autocrine and paracrine regulatory loops (Bussolino et al 2006 , Lee et al 2007 . For example, when carcinomas develop, epithelial cells can initiate incorrect signalling, resulting in stromal cell production of growth factors that, in turn, stimulate inappropriate proliferation of the secreting cells themselves (autocrine feedback) or of neighbouring cells (paracrine regulation). Focusing on mechanoreciprocity (Butcher et al 2009) while keeping for biomechanical regulations a similar conceptual framework, it may be useful to introduce autobaric and parabaric pathways through which cells influence themselves and each other through mechanical signals (Banes et al 1995 , Tracqui 2006 . Thus, autobaric processes define a self-enhancement of the cell stress state by the cell's own contraction, as illustrated in the mechanosensitive development of focal adhesions quoted previously. Parabaric regulatory loops may be initiated by a cell increasing its mechanical load over neighbours' cells by short-range mechanical deformation transmitted by the ECM. Figure 5 . Tumours induce blood vessel growth, i.e. angiogenesis, by secreting various growth factors like vascular endothelial growth factor (VEGF), which binds to receptors present on ECs membrane. ECs then release proteases, escape from the original parent vessel walls (sprouting) and migrate by chemotaxis toward the tumour where they form new vessels. Single tumour cells can break away from the tumour mass and enter one of these blood vessels, being then carried to a distant site where they can initiate the growth of a secondary tumour (metastasis).
EC chemotaxis
To what extent biophysical models of tumour growth already consider these diverse regulatory loops will be presented in the following sections. One should however stress that it is often difficult to isolate and analyse separately such regulatory loops, since they evolve together within a ECM that changes temporally as an adaptation to varying cell responses (Nelson and Bissell 2006) .
Tumour-associated angiogenesis
For maintaining tissue homeostasis and influx of oxygen and nutrients, formation and activation of blood vessels are essential during all tissue repair and growth processes as well as during cancer development (Avraamides et al 2008 , Cavallaro and Christofori 2000 , Folkman 2002 , Nyberg et al 2005 . When a primary tumour expands, the development of a new blood vasculature is required to sustain the metabolic needs of this rapidly growing cellular mass and to ensure the elimination of waste products. This is accomplished by activation of pre-existing vascular networks, a process referred to as angiogenesis, by opposition to vasculogenesis that defines the de novo formation of new vessels (Carmeliet 2003) .
During angiogenesis, a well-orchestrated series of events occurs, encompassing EC proliferation and further directional migration of these cells through remodelled basement membrane and stroma (figure 5). ECs respond to the angiogenic stimuli released by inflammatory cells and by the expanding populations of cancer cells constituting the tumour (Folkman 2003) . Further recruitment of perivascular support cells enables stabilization of nascent vessels, functional lumen formation and appropriate blood flow. Thus, tumour angiogenesis is a multifactorial process, regulated in part by local changes in the relative balance between soluble and insoluble either pro-or anti-angiogenic mediators, which impact on EC proliferation, differentiation, migration and 3D organization into tubular structures with functional lumen. Pro-angiogenic polypeptide growth factors comprise most notably different forms of VEGF (Lee et al 2007) , basic fibroblast growth factor (FGF) and tumour necrosis factor TNF (Gharaee-Kermani and Phan 2001, Gruss et al 2003) . These factors are highly expressed in developing tumours, as they are during physiologic wound healing. Availability of diffusible angiogenic inhibitors and stimulators is however limited, as they are either sequestered to ECM molecules or tethered to cells via membrane anchorage domains. Extracellular proteases like MMPs regulate the release of these factors, rendering them available for interaction with receptors on vascular cells and thus activating the development of tumourassociated vasculature. Intuitively, MMPs were previously thought to facilitate tumour expansion by merely degrading ECM structural components, thereby allowing a cleared path for migrating tumour or ECs. In fact, recent studies indicate that proteolytic degradation of ECM by MMPs release molecules that act as positive or negative regulators of tumour-associated angiogenesis, depending on host tissues and development stage of the tumour (Bergers et al 2000, Coussens et al 2002 , Lafleur et al 2003 .
Such considerations of biochemical regulatory pathways do not explicitly account for the morphogenesis of the tumour-associated angiogenic vasculature, which is distinctly tortuous and inherently unstable. In fact, while considerable information is known concerning the diverse assortment of positively and negatively acting soluble and insoluble factors regulating angiogenesis, less is known about the role of mechanical factors in the onset and modulation of vascular network morphogenesis. Significant insights into the mechanobiology of angiogenesis have come from the development and analysis of in vitro assays using cultured ECs (Vailhe et al 2001) . These assays, referred to as in vitro angiogenesis or tubulogenesis, mimic quite well the early morphogenesis of pseudo-capillaries networks, during which ECs cultured on ECM may organize as pseudocapillaries around the meshwork of growing areas devoid of ECM, the lacunae. Such patterning of ECs have in the last ten years attracted the attention of experimentalist and theoreticians by the intriguing fact that they appear to follow self-organizing rules (Gamba et al 2003 , Namy et al 2004 , Tosin et al 2006 , Tracqui 2006 . Several types of intervening (a) (b) Figure 6 . Adhesion of transformed EAhY926 ECs onto the surface of Cytodex © microbeads (diameter ∼200 µm) mimics the existence of outer rim of cells shedding from the tumour surface and interacting with the surrounding ECM. When focusing on one of these microcarriers (a), significant displacements (arrows (a)) of the viscoelastic fibrin matrix underlying the microcarrier can be reconstructed from time-lapse videomicroscopy sequences, revealing the field of traction forces generated by the cells. Interestingly, for soft enough fibrin gels, ECs self-organized into circular cellular chords (arrows (b)). This experimental feature illustrates how vessels morphogenesis could be sustained and modulated in a tumour microenvironment through stroma stiffness and cell-ECM mechanical interactions.
pathways have been identified, among which are cells-ECM mechanical interactions. Indeed, ECM may sustain the early morphogenesis of this capillary-like structures network by providing positional cues, by mechanically influencing microvessel cell behaviour in a given range of ECM stiffness (Ghajar et al 2008 , Stephanou et al 2007 , Vailhe et al 1997 and by transmitting mechanical loads imposed to neovessels during angiogenesis (Krishnan et al 2008) .
Interestingly, in vitro assays conducted with microbeads can illustrate how such self-organizing phenomenon could be induced from the outer rim of cells shedding from the tumour surface.
Following a previously described in vitro microcarrier-based angiogenesis assay (Nehls and Drenckhahn 1995) , we cultured transformed ECs (EAhY926 cell line) derived from human umbilical vein endothelial cells (HUVECs). EAhY926 cells were allowed to migrate onto microcarrier beads, generating an outer rim of cells. Then, microcarrier beads are laid down onto a fibrin gel and the outgrowth of the ECs is recorded by time-lapse videomicroscopy. Figure 6 illustrates two key features of this experiment. First, the centripetal displacement of the fibrin gel toward each microcarrier reveals the existence of significant cell traction forces generated by cells progressively shedding from the microbead (figure 6(a)). Second, the migration of cells from the outer bead surface, combined with cell-cell and cell-fibrin matrix mechanical interactions, result in a selforganized morphogenesis of a lacuna within the fibrin gel, surrounded by a circular chord of cells (figure 6(b) ).
This morphogenetic process occurs for a given range of fibrin gel stiffness, in agreement with data obtained from usual in vitro angiogenesis assays where ECs are initially uniformly seeded onto the fibrin gel surface (Stephanou et al 2007 , Vailhe et al 1997 , Vernon et al 1992 . This feature also illustrated how the sensitivity of tumour-derived ECs to the elasticity of the tumour microenvironment may contribute to normal or abnormal development of the local microvasculature (Ghosh et al 2008) .
A clear limitation of the microcarrier assay is that cell dynamics and interactions are limited to the microcarrier surface. This is not the case with multicellular tumour spheroids (MTSph), the most common in vitro assay developed to mimic solid tumour growth. Since a large number of the biophysical models reviewed in this paper have been developed and discussed with respect to this assay, we briefly present in the next paragraph the properties and major aspects of this experimental model.
In vitro models of tumour growth: MTSph
Many types of mammalian cells can aggregate into 3D structures named multicellular spheroids (figure 7). Since monolayer cultures of tumour cells cannot represent the characteristics of three-dimensional solid tumours, MTSph are well established in experimental cancer research as 3D structures of intermediate complexity (Mueller-Klieser 1997 , 2000 , Sutherland 1988 . One major advantage of MTSph is their reproducible concentric arrangement of the different cell populations found in tumours microregions. MTSph are thus excellent in vitro models for studying cell chemosensitivity, as well as intrinsic and acquired forms of resistance to anticancer agents. Structurally, the cross-section of MTSph reveals, starting from the spheroid centre (figure 8): (i) an inner necrotic core, which is largely variable depending on the cell type and on the culturing conditions, with a first layer of hypoxic quiescent cells, (ii) an intermediate well-oxygenated zone with quiescent cells, (iii) a well-oxygenated outer rim with actively proliferating cells (Mueller-Klieser 2000) . MTSph are usually classified into three groups according to the relative emergence of necrotic and hypoxic regions (MuellerKlieser 2000) . However, other factors may influence MTSph properties, as illustrated by the fact that not all malignant cells can form MTSph. Moreover, MTSph can hardly be vascularized when co-cultured in vitro with ECs, while they become vascularized following implantation into animals. Within the spherical shape, a concentric arrangement of large proliferating tumour cells is found in the periphery, while smaller non-proliferating cells concentrate in deeper regions. Diffusional constraints to oxygen and nutrients supply increase with spheroid size and a central necrotic core emerges as a result of cell death for a certain spheroid radius R. This value, which largely depends on the cell type and on cell culture conditions, is one of the main variables considered in MTSph growth models.
This indicates that MTSph properties are determined both by intrinsic properties of cells and by cell-cell and cellmicroenvironment interactions.
These considerations stimulate the design of experiments for mimicking tumour stroma influence. Evolution of the above standard MTSph outgrowth assay has been proposed by embedding MTSph in extracellular matrices, like agar (figure 7) or collagen, with tunable composition and stiffness. Thus, Helmlinger et al (1997) investigate the influence of external mechanical loading on MTSph by conducting experiments where carcinoma and sarcoma cells were growing in an agarose matrix. The matrix stiffness was tuned by varying the volume fraction of the solid component during the preparation. The spheroid growth was then constrained by resistive stresses fields with different magnitude. Experimental results showed that the size reached by the growing spheroid decreases as the stiffness of the gel increases. Concomitantly to the reduction of spheroid size, decreasing apoptosis rate and increasing cellular packing were observed.
Biophysical models of tumour growth took the benefit of such direct experimental analysis of structure to function properties, where the proliferative and metabolic properties of cells in spheroids are related to their radial position. Thanks to their well-defined spherical geometry, theoretical analysis of MTSph growth may use simple, radially symmetric or asymmetric models that will be repeatedly encountered in the different following sections, considering notably mechanical properties of MTSph in section 4 and irregular MTSph morphologies explained by shape instability scenarios in section 5.
Modelling avascular tumour growth

From temporal to spatially structured models
The modelling of avascular tumour growth is a first step toward an integrated description of tumour development and metastasis. The earliest and simplest models described the changes over time of the number of cancer cells within a solid tumour, with cell proliferation following an unlimited exponential growth law or more realistically Verhulst's (logistic), von Bertalanffy or Gompertz's growth laws (Afenya and Calderon 2000, Kozusko et al 2007a , Marusic et al 1994a , Retsky et al 1990 . The latter include slowdown and inhibition of tumour's evolution, due to contact inhibition between packed cells and deprivation of environmental resources. In addition to these standard models, alternative descriptions have been recently proposed (Bru et al 2003 , Delsanto et al 2004 , Kozusko and Bourdeau 2007b , looking for some universality in the characterization of the growth process. Restricted to the temporal aspects of tumour growth, these models reduce to a single ordinary differential equation whose solution can be successfully compared with experimental growth curves exhibited by in vitro growing MTSph (figure 7(c)) or in vivo growing tumours (Marusic et al 1994b , Retsky et al 1990 . However, as pointed out in Araujo and McElwain (2004) , such models are essentially mathematical descriptions, with model parameters hardly related to physical processes. This limits their explicative power, even if they can be extended to deal with tumour heterogeneity and the existence of subpopulations of cancer cells (polyclonality) emerging from genetic mutations and characterized by different proliferation rates and sensitivity to environmental or chemical cues.
In order to understand more precisely the influence environmental conditions have on tumour growth, notably nutrients delivery and acidity levels, spatially structured reaction-diffusion models have been developed as moving boundary problems, in which the position of the outer tumour boundary is unknown (Ferreira et al 2002 , Smallbone et al 2005 . The generic physical driving processes that will be commonly encountered in models are the diffusion of nutrients and oxygen, provided by the surrounding host tissue and consumed by tumour cells. Since oxygen and nutrient availability limits cell proliferation, the expected outcome of such models is the definition of conditions leading to the appearance of necrotic and hypoxic regions. When the tumour is small, nutrient availability stimulates the cell proliferation. As the tumour expands, cells located in the central part of the tumour are progressively starved of nutrient. Cell death increases, generating a necrotic core in regions when nutrient falls below some critical values (figure 8).
As a simplification, tumour cell density is no longer explicitly considered as a variable of these spatial models. The nutrient concentration n(r, t) and the tumour radius R(t) are the generic variables, with tumour cells proliferation assumed proportional to the local nutrient concentration. From a formal point of view, nutrient concentration is given by a reactiondiffusion equation. Coupled to the diffusion of nutrient (diffusion coefficient D n ), the rate of nutrient consumption depends on the tumour radius R(t) to account for tumour heterogeneity (figure 8), leading to the simple mass balance equation
Tumour growth is given by a differential equation, describing the rate of change of the tumour volume from the balance between the nutrient-dependent rates of cell proliferation and death. The main assumption (and limitation) of such models is to consider for simplicity the growth of a spherical tumour. This symmetry condition allows the determination of the tumour boundary expansion from the one-dimensional movement of the outer tumour radius R(t) in the radial direction (0, r) as the solution of the integro-differential equation (Byrne and Chaplain 1996a) :
where the functions G(n, . . .) and A(n, . . .) model indirectly cell proliferation and cell death, respectively, with R nc being the radius of the necrotic core. As growth proceeds, a multilayer architecture emerged within the tumour from the imbalance between supply and demand of nutrient. Thus, such models are simple and successfully reproduced the multilayered architecture of MTSph cultured in vitro, with an outer rim of nutrient-rich, proliferating cells, a central core of nutrient-starved, necrotic debris and an intermediate region of nutrient-poor, quiescent cells, as described in section 2.5. In addition, analytical and quantitative predictions are possible regarding (i) the time at which the necrotic core of the idealized tumour occurs, (ii) the size of the tumour at the onset of necrotic core formation, which depends on the model parameters values, notably the diffusion coefficient of the nutrient. Generalization of this diffusion-consumption scenario to other diffusing molecules (hydrogen ions, glucose, lactate, etc) and growth factors within reaction-diffusion models allows a more refined description of the control exerted by the host microenvironment onto the growing tumour (Casciari et al 1992 , Kelly et al 2008 , Smallbone et al 2005 . Thus, Gatenby et al (2006) explored an acid-mediated tumour invasion hypothesis, according to which acidification of the tumour microenvironment is toxic to normal cells, but advantageous to cancer cells, thus triggering the transition from benign to malignant tumour growth. Their model consists of three coupled reaction-diffusion equations for cancer cells, normal cells and pH, and simulates the death of normal cells induced by an increasing acidity generated by neighbouring cancer cells. The latest extension of this model gives a still more accurate description of the role of acidosis in tumour growth by considering the respective contribution of active and quiescent cells . Additionally, Swietach et al (2008) used diffusionreaction modelling to explore the potential of cell membrane enzyme for controlling the gradients of intracellular pH within a tumour, a more uniformly alkaline tumour favouring further growth.
These models, incorporating a limited number of biological processes and simple geometries, do not account for the observed irregular shape of multicellular spheroids or tumours. This consideration stimulated the development of models trying to include cell motility processes and cellular response to environmental cues.
Modelling tumour growth sustained by cell migration in response to environmental cues
Modelling tumour growth in connection with the invasion of tumour cells into the host tissue is a major challenge, since the switching on or off of this migratory stage has a dramatic influence on the induction of the metastasis process. We know from section 2.2 that direction and speed of cells migration depend on environmental stimuli, especially gradients of soluble chemicals (chemotaxis), gradients of substrate-attached molecules (haptotaxis) or ECM mechanical properties (mechanotaxis), including gradient of matrix rigidity (durotaxis) and 'substrate guidance' monitored by the topography and anisotropy of the microenvironment (figure 2). However, spatio-temporal evolution of such directional migration processes may become hardly predictable when the tumour microenvironment continuously varies in composition as a result of growth factors and ECM turnover, or in organization because of ECM deformations induced by cellular traction forces. A crucial property of biophysical models is then their ability to determine whether the coupling between tumour microenvironment evolution, cellular forces and active cell migration will sustain tumour growth or, conversely, might prevent its expansion (figure 1).
Theoretical models have incorporated different degrees of complexity to account for cell motility, either passively in a diffusive manner or actively in response to external cues. Mathematical differential expressions of some associated cellular fluxes are briefly introduced below.
A rather exhaustive presentation of such models can be found in the seminal books of J D Murray (2002 Murray ( , 2003 . Random cell motility is classically described by cellular diffusion, in which the diffusive cell flux J d is proportional to the local cell gradient ∇m(r, t) at location r, i.e. J d = −D∇m, where the cellular diffusion coefficient D can be identified from the analysis of cell tracking data (figures 2(a) and (c)) based on random walk or persistent random walk models (Rosello et al 2004 , Selmeczi et al 2005 . Instead of considering a constant diffusion coefficient, some models of tumour growth assumed that this parameter is a function D(m) of the cell density (selfreinforcement of cell motility) or depends locally on the ECM properties. We especially reported in section 2 that cell traction forces induce architectural reorganization and anisotropy of the fibrous tumour microenvironment at the invasive front. In agreement with experimental observations (Korff and Augustin 1999) , such influence of dynamic reshaping and distortion of the microenvironment onto cellular diffusion can be modelled by a strain-dependent diffusion tensor D(ε) here ε is the Cauchy's infinitesimal strain tensor (Cook 1995) . The cellular diffusive flux J d then reads
However, the most common directional cell motion invoked when modelling tumour growth remains cell chemotaxis, with cells moving up (more rarely down) gradients of a diffusible molecule (growth factor, cytokine, etc) like VEGF (Lee et al 2007 , Selmeczi et al 2005 . Cell chemotaxis has notably a pivotal role in modelling the reaction of the host immune system to tumour cells (Adam and Bellomo 1997) . In the simplest models, the chemotactic flux of cells J g is assumed proportional to the cell density m (r, t) and to the chemical gradient signal ∇g(r, t), with J g = αm∇g. The coefficient α defines the cell's sensitivity to the diffusible chemoattractant. In a similar way, active cell migration by haptotaxis, i.e. up to ligand-density gradients (or adhesivity gradient) is modelled by considering an haptotactic cell flux J h . In a first approximation, this flux may be considered proportional to both the local cell density and the ECM density gradient ∇e(r, t). Assuming that the sensitivity of the cell response to this gradient is monitored by a coefficient h (haptotactic cell sensitivity), the associated cellular flux is described by the phenomenological expression J h = hm∇e. Figure 9 illustrates that such modelling of haptotactic cell migration, in combination with cellular forces, can generate a self-enhanced accumulation of cells in specific regions of a deformable medium. More generally, the above expressions of cellular fluxes can be modified by considering that chemotactic or haptotactic coefficients are no longer constant parameters, but rather functions that depend on cell density or on microenvironment composition and structure, as illustrated above for cellular diffusion fluxes.
The above theoretical expression of cellular fluxes has been considered in a large class of continuous differential tumour models coupling reaction-diffusion equations with chemotactic and possibly haptotactic cell migration processes. Analysis of travelling-wave solutions exhibited by reactionmigration models provides a theoretical basis for studying in 1D domains tumour cells infiltration in the surrounding tissue in different contexts (Marchant et al 2000, Sherratt and . In 2D domains, consideration of cell motility in addition to competition for nutrients among normal and cancer cells was proven to give rise to a wide range of tumour morphologies. Thus, Ferreira et al (2002) derived from a nutrient-limited growth model a phase-like diagram exhibiting the transition from compact and circular morphologies to papillary and finger-like tumour patterns. Considering a 3D-geometry, Stein et al (2007) modelled the invasion of collagen gels by glioblastoma tumour spheroids. The model is designed to describe the dynamics in two distinct regions of the dispersive spheroid: the central core contains cells that proliferate rapidly but move slowly; the invasive rim contains cells that proliferate slowly but are highly motile, with radially directed motility. The model simulates the growth and morphologies of both the core radius and the invasive radius, which compare favourably to experiments on the patterns of growth and dispersion conducted with wild type and epidermal growth factor-transfected tumour cell lines. Interestingly, the authors reported that in two-dimensional radial migration assays, transfected cells exhibit a higher dispersion rate than wild-type cells, in agreement with observations made in animal models and with the reported implication of epidermal growth factor activity in the increased aggressiveness of many cancers. But surprisingly, the wild-type cells are more invasive than the transfected ones in the 3D spheroid/collagen assay, which points out the different influences of 2D and 3D extracellular environments on cell phenotype and behaviour (Martins and Kolega 2006) . In this case, wild-type cells would have a better ability to reshape the collagen matrix, forming preferential migration tracks which could increase directed cell motility. Such differences plead for a more accurate modelling of directional cell migration. Interestingly, a recent work of Gerisch and Chaplain (2008) introduced a refined analysis of cell-matrix adhesion by considering a sensing region for cells, with cell velocity being enhanced in the direction where cells can form the most bonds within the sensing region.
Control of tumour growth by mechanical factors: continuum mechanics based models
Including mechanical factors as control parameters for tumour growth is a conceptual change with respect to the above modelling frameworks focusing on cell population dynamics modulated by diffusible molecules. As outlined previously, tumour growth is fundamentally a biomechanical process with multiple facets, ranging from inherent balance between proliferative pressure and resistive force of surrounding host tissue to the far more complex processes of mechanical control of cells dynamics and tumour vascularization. Then, tumours should not be considered as passive mechanical structures, but rather as dynamic active media where mechanical signals can be transduced in different ways to determine the differential response of normal and cancer cells, respectively (figure 4).
Biophysical models that are grounded within a mechanical framework aim at answering questions about the influence of strains and stresses on the evolution of the tumour structural and mechanical properties itself, on the mechanical interactions between the different types of cells inside and outside the tumour, and between these cells and the tumour microenvironment. This section highlights representative modelling approaches proposed in this context, from the earliest models introducing pressure and surface tension of the tumour to more recent approaches dealing with multiphase models and introducing diverse strain energy functions to describe constitutive stress/strain relationships within the tumour.
Modelling the effect of pressure within the tumour and associated cell velocity field
Following the work of Greenspan (1976) , the role of cellcell adhesion as a physical constraint regulating tumour compactness was addressed by several groups Chaplain 1996b, Cristini et al 2003) . In these models, cellcell adhesion was introduced by considering surface tension at the tumour outer rim as a control parameter for tumour reshaping during growth. Tumour growth itself is driven by the intratumoral pressure gradient ∇p generated by localized cell proliferation. Such gradients induce motion of tumour cells, away from the proliferation regions (high pressure) and towards regions where cell death predominates. However, cell density does not appear explicitly as a model variable and a key variable remains as usual the nutrient concentration delivered by the microenvironment. Its evolution still obeys a reactiondiffusion equation, assuming additionally that a steady-state distribution has been reached, since the time scale of the growing tumour is much slower than the diffusion time scale of the nutrient. Considering the tumour as an incompressible fluid, it is assumed that cell proliferation and death produce a velocity field v linked to the nutrient concentration through the continuity equation ∇ · v = (n), where (n) represents the net balance between the nutrient-dependent proliferating rate and the cell death rate (Cristini et al 2003, Graziano and Preziosi 2007) . A constitutive equation is needed to relate the velocity field to the internal pressure p. The usual assumption is to view the tumour as a porous medium through which the tumour cells flow. Then Darcy's law is used to relate the velocity v to the pressure gradient, i.e. v = −γ ∇p, where γ is a positive constant characterizing the hydrostatic, viscous-like properties of the tumour cells Preziosi 2003, Macklin and . On the free boundary of the tumour, which moves with velocity v, different types of conditions expressing tumour compactness are provided to close the model formulation. Thus, mean curvature and surface tension accounting for cell-cell adhesion can be used to prescribe boundary conditions on the pressure or on the nutrient concentration (Byrne and Chaplain 1996b) .
A main departure of such models from those assuming radially symmetric tumour morphologies is their ability to deal with the influence of tumour shape and local curvature, and thus to cope more realistically with the diversity of irregular tumour morphologies observed experimentally. Furthermore, it becomes theoretically possible to characterize parameter regions for which the radially symmetric solution becomes unstable to asymmetric perturbations. This represents a first basis for understanding the emergence of tumours with branching morphologies, as detailed in the next section. On the other hand, several limitations of these modelling approaches can be pointed out. From a physical point of view, the validity of Darcy's law to describe cell motion within the tumour may be questionable. Modelling tumours as freely expanding bodies, keeping a relative compactness thanks to cell-cell adhesion processes, is also a rather simplified view of the real experimental situations, only justified in the case of free floating growing MTSph. In other cases, a growing mass of tumour cells contends with increasing mechanical resistance from the surrounding host tissue, as experienced in vitro by MTSph growing in gels (section 2.5). In vivo, this constrained growth has fundamental implications regarding the formation of a dense capsule of extracellular material around the tumour. A crucial issue is then to know under which conditions such physical barrier will be sufficient to contain tumour growth and to prevent dissemination of cancer cells and metastasis.
In the light of preceding sections, analysis of tumour encapsulation may invoke two kinds of processes: (i) a passive mechanical response of the surrounding tissue, which is simply compressed into a capsule by expansion of the tumour (expansive growth hypothesis), (ii) active response of the host tissue, with induction of ECM biosynthesis by normal cells. These two processes have been analysed by Jackson and Byrne (2002) , with spatio-temporal evaluation of cells and ECM (the model constituents or phase variables) simulated when both processes are considered to act either independently or synergistically. Stresses inside the tumour include for each constituent intraphase stresses, depending on the constituent volume fraction, and interphase stresses, including frictional drag due to the relative motion between two constituents. Cell proliferation and matrix production are inhibited at high cell and ECM densities. The model is furthermore considered as a closed system, with the sum of all constituents being constant. One-dimensional model simulations indicate that without ECM production, tumour growth generates thin capsule, without growth suppression. With ECM production, ECM accumulates within the tumour. With both processes acting, tumour is growing and surrounded by a thin and dense capsule. Closer to the biological observations, and in order to analyse how the local host stroma is affected by degrading enzymes produced by the tumour itself, the model extension proposed by Jackson and Byrne (2002) considered that tumour cells produce protease at a constant rate when the pressure they experience exceeds a threshold value. In addition, proteases enhance motility of the cell by weakening cell-cell interactions and adhesion. As expected, protease activity induces capsule breakdown and favours tumour expansion.
In section 1, we highlighted that the active response of the host tissue to tumour expansion is similar to a wound-healing response, which, in addition to collagen and extracellular proteins synthesis, can induce differentiation of fibroblasts into migrating myofibroblasts able to contract the tissue. In an attempt to analyse the role of tumour microenvironment contraction on potential tumour encapsulation in the absence of ECM biosynthesis by normal cells, Lubkin and Jackson (2002) proposed a fluid mechanics approach to discriminate between expansive growth and active contraction scenarios. They consider both the host tissue and the tumour to be composed of two interpenetrating material phases, a first aqueous phase for the interstitial fluid and a second phase consisting of normal and tumour cells embedded in fibrous extracellular components. They assume that, on the time scale of tumour growth, the second phase behaves as a Stokes fluid. Still commonly assuming that tumour cell proliferation is a function of available nutrients concentration, the model introduces two kinds of stresses, the so-called solvation and contractile stresses, respectively. The solvation stress is a measure of the affinity of one phase for another, with positive values if the cell-ECM phase is strongly hydrophilic, and negative values if the cell-ECM phase is hydrophobic. The contractile stress, modelling the potential contraction of the host tissue, is proposed as an interaction term proportional to the normal and tumour cells densities. Simulations of this simple three-parameter model indicates that contractility of the surrounding host tissue is not needed for the formation of a capsule, but that this process may be enhanced if host tissue contractility additionally takes place.
More recently, Guiot et al (2006) developed a rather different approach by considering a mechanistic description of tumour invasion in the framework of solid inclusion growing in an elastic fracturable medium. The transition from a noninvasive growth to invasive patterns takes place when a failure stress, corresponding to a threshold for fracture propagation, is reached. The so-generated cracks provide a mechanistic analogy for the generation of infiltration paths for tumour cells within the host tissue. The considered tumour growth model implements the isotropic growth of a spherical and linear elastic inclusion inside a linear elastic medium, the growth rate being inhibited by the interfacial pressure. In the standard case of a linear elastic microenvironment, the model predicts very satisfactorily the time evolution of the volume of non-invasive spheroids of human adenocarcinoma cells growing in agarose gels with increasing stiffness (Helmlinger et al 1997) . When a fracturable elastic microenvironment is considered, Guiot et al (2007a) also reported a very good agreement between the model simulations and observed rates of volume growth obtained experimentally with invasive glioma spheroids (Gordon et al 2003) .
Modelling the role that stress responsiveness may play in controlling tumour growth
As underlined previously, solid tumour expansion occurs within a deformable host medium that mechanically constrains the growth process. Quite naturally, biophysical modelling of tumour growth is thus part of a general framework dealing with development and influence of stress field on growing biological tissues (Cowin 2004 , Humphrey 2003 , Lin and Taber 1995 , Volokh 2006 , occurring during both physiological and pathological morphogenetic processes.
In this context, a rather large diversity of biophysical models have been considered, with tumour being considered as one component of multiphasic medium exhibiting viscous fluid-like or elastic solid-like properties. Experimental data indicate that, according to their cellular origin (carcinoma, sarcoma, glioma, etc), tumours develop with different mechanical properties. Thus, Netti et al (2000) reported significant differences in the stress relaxation behaviour of tumours obtained from various human tumour cell lines and grafted in mice. When submitted to a sequence of compressive strain within a confining chamber, the studied carcinomas exhibit a viscous behaviour, with almost complete stress relaxation in between the imposed strains, which is typical of macromolecular solutions. Conversely, the tested glioblastoma and sarcoma display a viscoelastic solid type of behaviour, with sequential increase of stress with strain. Additionally, a significant nonlinear dependence of the relaxation phase with strain was observed with glioblastoma (Netti et al 2000) , which closely resembled the one observed with extracellular fibrin matrix submitted to similar loading conditions (Benkherourou et al 2000) . Such tumours thus behave as structured soft tissues. Thus, these experiments provide quite relevant quantitative data for modelling tumour growth in a continuum mechanics framework.
In the continuum mechanics approach of Ambrosi and Mollica (2004) , the tumour spheroid was considered as compressible elastic solid whose increase in mass with time is modulated by nutrients levels. A known modelling difficulty is then to describe simultaneously the change in mass and in stresses occurring during growth. The usual approach (Rodriguez et al 1994) consists of describing the evolution of the mechanical properties of the growing tumour as a composition of two separate transformations. The first one considers the change in mass due to growth from the initial configuration up to an intermediate and virtual, so-called natural configuration, and is described by a growth tensor G (figure 10). The second transformation describes the stress response of the tumour up to the current configuration. For simplicity, the newly synthesized material is introduced with the same stress state as the existing material. A constitutive relationship has to be provided to model the stress response from the natural configuration.
By analogy with polymeric foams, Ambrosi and Mollica (2002) considered the tumour as an isotropic nonlinear elastic and compressible material characterized by a strain energy function, from which the Cauchy stress tensor T in the tumour can be derived. This constitutive equation is Since this stress-free configuration may differ from the observed current configuration, an elastic transformation F e describes the stress response of the tumour from the natural to the current configuration, tumour mass being preserved. The overall deformation gradient F indicates how the growing tumour is deforming locally when going from the initial to the current configuration. The transformation F e gives rise to a residual stress T r in the current configuration.
supplemented by the usual mass balance equations for the tumour mass and the nutrient, and by the balance of linear momentum, which sums up to divT = 0 when inertial terms and body forces are neglected. Key points in the model formulation are the expression of the growth rate appearing in the tumour mass balance equation and the associated relationship between the growth rate and the growth tensor G. Isotropic growth of a sphere can be modelled with a growth tensor of the form G = g(t)I , where the identity tensor is multiplied by an explicit function of time g(t). More interestingly, and with reference to Helmlinger et al (1997) experiments reporting inhibition of tumour spheroid growth with increasing stiffness of the surrounding agarose matrix (section 2.5), Ambrosi and Mollica (2004) considered that the spherical growth tensor G depends on nutrient concentration and on intratumoral stress. Conservation of mass leads to a growth model where the function g(t) is given by a differential equation g t = h(trace P , n)g, where n is the nutrient concentration and P the first Piola-Kirchoff stress tensor, introduced to solve the mechanical problem in the reference configuration. The dependence on stress is modelled through a decreasing exponential function, such that stress always inhibits growth. Additional constitutive equations are prescribed for the mechanical behaviour of the agarose gel. The mechanical response of this matrix, considered as a poroelastic material, is derived from a strain energy function depending both on the third invariant and, exponentially, on the first invariant of the right Cauchy-Green deformation tensor. Corresponding simulations of tumour spheroid growth showed that in the absence of external loads (floating spheroid), the change in growth rate was essentially due to the reduced availability of nutrient that occurs when the diameter of the spheroid increases. A significant nutrient concentration only subsists in a thin layer below the spheroid surface, which may be interpreted as the outer rim of proliferative cells observed experimentally with MTSph assays. When the spheroid is growing within the surrounding poroelastic medium, its size increases linearly from the very beginning, until it tends to plateau. In this case, growth is essentially inhibited by extracellular stresses. Let us remark that an additional complexity in the description of MTSph growth is the intrinsic generation of residual stresses, a rather common feature observed with different physio-pathological processes (Alford et al 2008 , Ohayon et al 2007 , but which may significantly influence the tensional homeostasis of the growing and remodelled tissue (Alford et al 2008 , Ambrosi et al 2008 , Lin and Taber 1995 .
While the tumour spheroid model of Ambrosi and Mollica (2004) is one-component, the growth of MTSph embedded in a compressible elastic matrix was alternatively modelled by considering a growing structure composed of solid and fluid phases in interaction. Following Landman and Please (2001) , Chen et al (2001) considered the tumour spheroid as a mixture of cells and extracellular fluid characterized by their volume fraction and velocity, related through force balance equations involving hydrodynamic drag force, hydrostatic pressure and intercellular forces. Growth takes place through cell proliferation and mass exchange between phases, with dead cells assumed to transform into fluid phase. The spherically symmetric spheroid then consists of a necrotic region, resulting as usual from diffusion-limited nutrient supply, and of a compact but active outer proliferative rim. The spheroid's expansion is restrained by the surrounding matrix, still modelled as an infinite hyperelastic isotropic and compressible medium characterized by a strain energy function, which is a slight modification of the strain energy function proposed by Helmlinger et al (1997) : it depends on the first and third strain invariants and is similar to the one used in (Ambrosi and Mollica 2004). As intuitively expected, the ECM inhibits the tumour spheroid's growth, but the 1D simulations of the model allow a quantitative tracking of the sigmoïdal pattern exhibited by the evolution with time of the spheroid matrix interface, together with the associated rapidly varying displacement of the necrotic core.
The biomechanical models presented above can be certainly extended by taking into account additional properties characterizing tumours mechanical response to extracellular strains and stresses. One may notably consider more precisely how the mechanical confinement surrounding the tumour mass feeds back onto tumour remodelling through variation of mechanical moduli characterizing the tumour properties. Such analyses can be conducted in a multiphase modelling framework (Preziosi and Tosin 2009) or transposed from studies developed in other fields, e.g. when analysing stress adaptation of bone or heart tissue: here tissue stiffness is a function of microstructures which evolve in time depending on the external loading conditions (Cowin 2004 , Taber and Chabert 2002 , Tozern and Skalak 1988 . Aside from pure tumour mass expansion, the mechanical effects of cell traction forces onto the alignment and anisotropy of the fibrous tumour microenvironment also appear as critical active controls of tumour expansion, as developed in the following section.
Morphological instabilities at the tumour/stroma interface and tumour invasion
Tumour invasion involves a variety of processes that ultimately lead to cell detachment from the primary tumour and infiltration into adjacent tissue and before possible dissemination to secondary metastatic sites with the aid of the bloodstream system (figure 5). We already approached in the preceding section a challenge in modelling tumour growth, namely understanding how the propensity of limiting tumour expansion by compression and fibrosis of the host tissue may be redirected to the capacity of triggering invasive progression and further metastasis capabilities of tumour cells (figure 1). Considering the invasive branching morphology commonly observed in vitro with growing MTSph, a promising view consists of approaching this pattern formation process as the result of the amplification of growth instabilities at the tumour/host tissue interface. Thus, the landmark of tumour aggressiveness would not be solely a localized tumour cell proliferation, modifying the tumour's surface-to-volume ratio, but a global switch or bifurcation between 'smooth margin' and 'fingering protrusions' surface patterns. In this framework, biophysical models are expected to shed light on the selection of invasive patterns by the tumour microenvironment characteristics, i.e. nutrient availability, growth factors activity and ECM properties.
We outlined in the preceding section that 1D models focusing on surface tension (Greenspan 1976) or cell-cell adhesion (Byrne and Chaplain 1996b) as the biophysical processes maintaining the tumour's compactness exhibit parameter regions for which the radially symmetric solution becomes unstable to asymmetric perturbations. Both processes yielded similar qualitative predictions: regular tumour growth occurs if surface tension or cell-cell adhesion is strong enough, but irregular, infiltrative structures resembling irregular outer boundaries of tumours emerge if these parameters are smaller.
Alternatively, the emergence of non-equilibrium steady states as dissipative structures is well documented in reactiondiffusion models or in reaction-diffusion-migration models of pattern formation (Murray 2002, Nicolis and Prigogine 1977) . In the original model proposed by Turing in 1952 (Turing 1990 , the so-called Turing's instability arises from the coupling between nonlinear reaction kinetics and the relative diffusion of two competing (inhibitor and activator) chemical species. In reaction-diffusion-migration models, simplest scenarios involve cells that produce their own chemoattractant. Then a small perturbation in an initially homogeneous distribution of cells gives rise to a gradient of chemoattractant that enhances the heterogeneity of cell density. On the other hand, cellular diffusion, as well as chemoattractant diffusion, tends to eliminate such heterogeneities. Clearly, spatial patterns will be generated if the aggregative process is greater than the dispersive effects. A similar self-enhance aggregative effect can be driven by adhesivity gradients (haptotaxis), exhibited by inhomogeneous ECM densities (figure 9) (Murray 2002 , Tracqui 2006 . This aggregative effect is still counterbalanced by cellular diffusion, but since ligands are bounded to the ECM and do not diffuse, it is only the ECM viscoelastic properties which can act as a stabilizing factor in this mechanical instability scenario (figure 9).
In view of these many possibly different sources of instabilities, several theoretical and computational approaches have been developed to sustain the view that nonlinear and self-organizing processes may drive tumour morphological instabilities, with clusters of cells organized and distributed non-homogeneously at the tumour edge as a response to a biochemical pre-patterning (figure 11). Thus, in the spirit of Turing's pre-patterning theory, Chaplain et al (1995 Chaplain et al ( , 2001 ) studied the evolution of the concentrations of growthinhibiting and growth-promoting diffusive chemicals, which are produced by the tumour cells on the surface of a growing spherical tumour. This surface is defined as a thin layer of proliferative cells, within which the production of the chemical factors is restricted. By assuming that the two chemical species u and v interact nonlinearly through cross activatorinhibitor mechanisms, it is known theoretically that linearly stable steady-state values of u and v in the absence of diffusion may bifurcate toward unstable solutions when diffusion comes into play. The growing tumour is modelled as a sphere of radius R(t), and the reaction-diffusion model is defined as a movingboundary problem that reads
where f (u, v) and g(u, v) are polynomial functions of u and v incorporating an order-2 autocatalytic formation of chemical u as the driving nonlinearity of the reaction terms. Given a set of parameter values, which satisfy the conditions for Turing's instability, different spatially heterogeneous steadystate distributions of the two chemicals u and v can be obtained over the tumour surface. As in rectangular geometries, higher order unstable modes become excited as tumour grows and tumour surface becomes larger. This leads to a series of spatial pre-patterns of growth-inhibitor and growth-activator concentrations (figure 11) that may be associated with the progression and asymmetries of tumour morphologies.
Another conceptual approach, based on the principle of 'least resistance, most permission and highest attraction' has been proposed by Deisboeck and coworkers (Deisboeck et al 2001 , Habib et al 2003 . In this scenario, cells follow each other because of reduced mechanical resistance of the ECM, enhanced haptotactic gradient, and increased chemical attraction, all as part of a self-organizing adaptive system. Following these guidelines, Sander and Deisboeck (2002) analysed and modelled the emergence of branching pattern around the central core of muticellular glioma spheroids, generated from a mutant cell line in which the gene coding for the epidermal growth factor receptor (EGFR) was amplified. The spheroid was cultured between two layers of ECM. In addition to random cell motion, the model implements two types of directional migration for tumour cells, called heterotype and homotype chemotaxis, respectively. The first one refers to the usual chemoattraction of cells in response to gradient of a diffusible nutrient supplied by the tumour environment. The second one refers to paracrine stimulation, according to which tumour cells produce soluble growth factors during their migration. Neighbouring cells are attracted by the so-created growth factor gradient, with motile cells following each other because of this chemotactic process. The 2D variation of the concentration of motile tumour cells is thus given by an extended diffusion-chemotaxis transport equation, which reads
Here c(r, t) is the concentration of cells, and n(r, t) is the nutrient concentration. The coefficient χ (n) is a nonlinear function of n, which defines the sensitivity of cells to heterotype chemotaxis. The last term is the homotype chemotaxis, mediated by the concentration h(r, t) of the paracrine mediator produced by motile cells. Proliferation of cells is assumed negligible in the invasive region, but cell generation counterbalancing cell shedding is implemented as a boundary condition on the spheroid surface. Diffusionreaction equations are additionally provided for nutrient and homotype factor concentration, assuming a steady-state distribution for the nutrient due to its much faster diffusion. A linear stability analysis of a schematic 2D portion of the region surrounding the spheroid shows that the steady-state concentration of the growth factor is unstable. Then, a branch of invasive tumour cells may extend from the spheroid surface as a result of this intrinsic instability due to the combination of heterotype and homotype chemotaxis. One should notice that formally, the last term in equation (4) looks like a haptotactic flux, except that molecules of h can diffuse. Tumour cell haptotaxis at the tumour surface was proposed in Tracqui (1995) as a possible driving mechanism for surface pre-patterning of invasive tumours, in conjunction with deformation of the tumour-host tissue interface by cellular forces. Considering the few layers of active cells at the tumour surface, the model assumption is that haptotactic cell movement initiates local cell aggregation, with an associated local increase in cellular forces amplitude and tumour stroma deformations which positively feedback onto cell motion. If haptotaxis is sufficiently large compared to cellular diffusion, this autocatalytic process can be strong enough to overcome the mechanical resistance of the tumour stroma, thus initiating and stabilizing the formation of preinvasive spurs of cancer cells at the tumour surface.
Quite recently, Macklin and Lowengrub (2007) proposed a more refined analysis of the crucial role played by the tumour microenvironment. In particular, they show that, in a nutrient-poor microenvironment, the only viable invasion strategy for the tumour is to break into small fragments, which penetrate the surrounding tissue. Conversely, under nutrientrich conditions, the tumour behaviour depends mostly on the biomechanical property of the medium: a soft, mechanically responsive medium enhances 'smooth margin' invasion while, in the opposite situation, long invasive fingers are produced, whose characteristics largely depend on cell-to-cell adhesion. Alternatively, the instability scenario explored by Khain and Sander (2006) is based on a dynamical switch of the tumour cells phenotype. They compared the invasive patterns obtained with mutant MTSph, where mutant cells were also obtained by amplification of the EGFR gene, to the spherically symmetric pattern observed with MTSph composed of wild-type, i.e. non mutated, cells. The model assumptions are that cells have high motility but slow proliferation in the spheroid neighbourhood, whereas rapid proliferation occurs in the inner spheroid region. Thus, Khain and Sander (2006) introduced an autocatalytic-type of density-dependent proliferation, leading to a two-variable nonlinear reaction-diffusion model similar to the one used in Chaplain et al (2001) . As known from 2D-analysis of such nonlinear systems, plane wave solutions can become transversally unstable if the ratio of the nutrient and cell diffusion coefficients exceeds a threshold value. Bifurcation of spherical spheroid shape toward developing branches of tumour cells is then associated with this instability phenomenon. When considering additionally that ECM reorganization due to cell/ECM interaction enhances tumour cell migration in the radial direction, the simulated developing branches appear much thinner than in the isotropic diffusion case. Thus, this simple reaction-diffusion model captures different in vitro morphologies of mutant and wild-type spheroids. It deserves nevertheless further experimental validation of the associated model predictions, i.e. that wild-type cells have a larger diffusion coefficient but a smaller proliferation rate than mutant cells in the spheroid microenvironment.
A diffusional instability scenario that takes place during tumour growth was also considered by Cristini and coworkers (Cristini et al 2003 , Frieboes et al 2006 . In their model, the local specific mass growth rate is given as the divergence of the tumour cell velocity field v, related to the pressure in the tissue by Darcy's law. Tumour cells and ECM are treated as comprising porous media with hydraulic conductivity, while cell adhesion forces are modelled using an equivalent surface tension at the tumour/tissue interface. Diffusing nutrient and oxygen are supplied by neovasculature and captured by tumour cells. The onset of morphologic instability and tumour fragmentation is based on the 3D linear stability analysis of the reaction-diffusion model, where mass growth and shape evolution of the tumour depend on four microphysical variables: cell mitosis rate, diffusion length L, ratio A of cell death rate over proliferation rate and ratio Gm of tumour cell mitosis rate over relaxation rate, where the relaxation rate is associated with cell-cell adhesive forces and cell motility coefficient introduced in Darcy's law. The bifurcation diagram associated with the model defines transitions between tumour morphologies as a function of A and Gm. For small Gm, the spherical shape is stable and the balance between cell proliferation and death regulates the tumour size. When too weak cell adhesion forces lead to larger values of Gm, shape instability may develop. These theoretical results are in agreement with observations of MTSph invasive morphologies and support a diffusional instability scenario where emergence of irregular tumour morphologies is driven by the differential cell proliferation induced by gradients of nutrients and growth factors in the tumour microenvironment (Frieboes et al 2006) . However, extrapolation to in vivo situations is not straightforward, since tumours in vivo possess varying degrees of vascularization and exhibit a complex interface with normal cells and the ECM. This provides a clear incitation to develop more complex models including explicitly tumour vascularization.
Tumour-host tissue interactions and tumour vascularization
The switch from the slow and relatively harmless avascular tumour growth phase modelled above to a rapid vascular growth phase occurs because of tumour vascularization by angiogenesis (figure 5). Therefore, biophysical modelling of tumour growth should be ideally able to couple tumour mass growth to the well differentiated stages of vascularization presented in section 2 and which build up tumour vasculature from the derivation of existing host tissue vessels (figure 5).
Thus, several approaches, based on continuous (Holmes and Sleeman 2000, Levine et al 2001) or discrete formalisms (Anderson and Chaplain 1998 , Bauer et al 2007 , Chaplain et al 2006 , Merks et al 2006 , tried to provide a global description of successive events leading to tumour vascularization, from loss of interconnection between the ECs and release of proteolytic enzymes in response to diffusible angiogenic factors secreted by tumour cells, to capillary sprouts, tips formation and interconnection into closed loops (anastomosis), until new capillaries penetrate the tumour (figure 5). In models of capillary network morphogenesis and adaptation to blood circulation, tumour is usually only viewed as a source of angiogenic factors. We will concentrate here on models explicitly coupling the influence of tumour vasculature on tumour growth, which have been significantly improved in recent years. Cristini et al (2005) related tumour shape and microvascular density to provide evidence that spatially homogeneous oxygen and nutrient act by suppressing morphological instability.
Their model incorporates an angiogenesis component as reinforced random walk of new blood vessels drawn into the tumour, and blood vessel will collapse when the blood-to-tumour pressure difference approaches zero. The two-dimensional simulations of the model were interpreted and summarized into a two-parameter phase diagram summarizing possible tumour morphologies: one parameter is associated with cell adhesion forces, while the other one quantifies microvascular density.
Model computations show that even after angiogenesis, the tumour maintains a compact morphology because of high cell adhesion. However, with a smaller value of the cell adhesion parameter, a morphologic instability of the tumour mass arises as the tumour develops. Such computational results can be discussed in the light of the tortuousness and loss of vascular hierarchy observed in solid tumours (Fukumura and Jain 2007) . Indeed, ideal angiogenesis will lead to a compact and spherical tumour mass confined in a limited volume of tissue. In this case, further tumour growth requires additional angiogenesis to increase nutrient access. In contrast, disordered vascularity leads to instability and tumour branching since the same tumour mass does not critically require angiogenesis for further growth and thus might extend across a larger region within the host tissue.
Recently, the same group (Frieboes et al 2007) proposed an extended 3D model of tumour growth still focusing on the influence on tumour angiogenesis and associated nutrients diffusion gradients onto tumour invasion. Their hybrid continuum-discrete model of tumour angiogenesis is based on convection-reaction-diffusion equations governing the dynamics of tumour cells, vital nutrients and cytokines. Mechanical interactions of the ECM with evolving neovasculature are modelled by adhesion energy and momentum equations based on Darcy's law and equilibrium among pressure and elastic forces. The model predicts gross morphological features of growing tumours, with regions of viable cells, necrotic areas and fractal-like neovasculature. Interestingly, the model accounts for the tumour engulfing and compressing the vessels, thus increasing necrosis. This result highlights the parabaric feedback loop that affects the angiogenic pathway described above: growing around capillaries that are usually immature, the tumour compresses them and might cause their collapse. But in turn, this increases hypoxia of the surrounding tissue, which stimulates secretion of angiogenic factors and thus the formation of new capillaries.
Additionally, adaptation of the vessel network to circulating hydrodynamic blood flow, with local vessel dilation, is a regulation process increasingly considered both during host tissue vascularization and during tumour growth (Chaplain et al 2006 , Stephanou et al 2005 . Thus, Lee et al (2006) considered the tumour-vessel system as a dynamically evolving graph interacting with tumour growth.
Interactions between tumour and vasculature take place via two concentration fields: the oxygen supplied by the vessel network and growth factors secreted by tumour cells. Each edge of the generated graph represents a tubular vessel carrying a hydrodynamic blood flow that exerts a shear force upon the vessel walls. Vessel dilatation takes place in regions of large growth factor concentrations. Conversely, weakly perfused vessels can collapse when the hydrodynamic shear force is too low. As a result, geometry of the tumour vasculature emerges in the model as a combination of dense and void regions that might possess fractal properties.
By coupling tumour growth to tumour angiogenesis, such models have obviously strong medical implications for understanding potential failure of anticancer chemotherapy due to insufficient drug delivery to the tumour. They also reinforced the multiscale properties of tumour growth and the benefit that could be expected by developing models addressing the specificity of biological and biophysical processes expressed at each level.
The next section briefly reviews some representative models developed in this perspective.
Multiscale modelling of tumour growth
A major issue in cancer research, as in other domains of physiopathology, is to handle the enormous amount of data produced at the molecular, cellular and tissular levels, both in normal and pathological contexts. Thus, multiscale biophysical models of tumour growth are especially important as formal and explicative tools for relating molecular processes and gene expression to global tumour morphologies (figure 12).
In the Jiang et al (2005) model, avascular tumour growth spans three distinct scales. At the cellular level, a lattice Monte Carlo model describes cellular dynamics (proliferation, adhesion and viability). At the subcellular level, a Boolean network regulates the expression of proteins that control the cell cycle. At the extracellular level, reaction-diffusion equations describe the chemical dynamics (nutrient, waste, growth promoter and inhibitor concentrations). This model produces an avascular tumour that quantitatively mimics experimental measurements in multicellular spheroids. Based on the simulations, the model predicts (i) the microenvironmental conditions required for tumour cell survival and (ii) the pattern of spheroid growth curves under different external nutrient supply conditions. Later, Anderson et al (2006) analysed the evolution of tumour morphology driven by selective pressure from the microenvironment, thanks to a multiscale model of cancer invasion where cell mutations and interaction with different types of microenvironment, referred to as homogeneous, 'bumpy' and 'grainy', are considered. Sharing some analogies with the granular solid considered by Guiot et al (2007a) , bumpy and grainy media represent density variations of the microenvironment taken at a cellular scale or at a macroscale, respectively. The approach of Anderson et al (2006) is based on a hybrid discrete-continuum model in which cells are treated as discrete entities, while microenvironmental factors are modelled as concentrations. Tumour morphologies emerge as a consequence of the cell collective behaviour, controlled by microenvironmental factors that influence cell mutations. In the model, these mutations occur at the time of cell division, either linearly through four increasingly aggressive phenotypes, or randomly through a mutation jumping process in which cells are allowed to acquire one of one hundred predefined phenotypes. A striking result of the random mutation scheme is that, even though each phenotype is equally likely to be chosen, only a few, aggressive phenotypes, are actually selected. Thus, the simulated growing tumour evolves toward increased aggressiveness, characterized by tumour cells exhibiting the shortest lag time to proliferation, the highest production of ECMdegrading proteases and the highest haptotactic migration rate. Interestingly, these phenotypic differences correlate with emergent tumour morphologies that are affected by the microenvironment structural properties: under homogeneous conditions, tumour morphology is non-invasive with smooth margins, as opposed to the invasive morphology with fingering margins simulated when tumour develops in the heterogeneous matrices. Thus, heterogeneous tumour microenvironment seems to drive cancer cells mutations toward phenotypes characterized by higher motility and higher haptotactic sensitivity.
Tumour growth models incorporating anticancer treatments: model-driven evaluation and optimization of therapeutic designs
A major application of tumour growth model development is the expected ability to derive from the dynamics and behaviour of virtual tumours some practical guidelines based on a model-driven optimisation of the tumour response to different types of anticancer treatments, including chemotherapy, radiotherapy, surgery, etc, while diminishing the unavoidable side effects of such treatments. Successes and limitations of theoretical models explicitly including and comparing anticancer therapies are exemplified here, with special consideration of brain tumours.
Briefly, the development of brain tumours, after diagnosis, is routinely recorded by different and accurate medical imaging techniques (computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) (Spence et al 2008), etc) . Typically, serial scans can lead to a quantification of the expensive or treatment-induced recessive dynamics of the brain tumour for each patient. Different models have been developed to analyse the different stages of a brain tumour growth (Murray 2003 chapter 11, Harpold et al 2007 . Their biological and physical bases do not differ significantly from those considered in the models reviewed previously. All models consider cell proliferation and cell infiltration as fundamental processes, possibly together with the compression of the brain tissue surrounding the tumour. In addition, geometrical constraints to brain tumour growth can be accurately taken into account in the modelling approaches, thanks to the different modality of image acquisition than can be used. These constraints encompass anatomical boundaries, either fixed as the skull, or displaced and deformed by tumour expansion, like the brain ventricles. Such geometric confinements significantly affect the size and shape of the tumour, notably if the tumour initiates close to these boundaries. These properties were highlighted with continuous tumour growth models, in which tumour growth-permitting regions versus tumour growth-prohibiting regions are defined through spacedependent diffusion coefficients (Tracqui et al 1995, Tracqui and Mendjeli 1999) . Alternatively, similar conclusions can be drawn using the cellular automaton approach, as recently reported by Gevertz et al (2008) , with automaton cells defined from the Voronoi tessellation of the considered tissue. A benefit of this latter approach is to consider intercellular mechanical stress between cells as a control parameter for the tumour expansion, thus incorporating the mechanical feedback exerted by the environmental confinement on the tumour growth.
Brain tissue heterogeneity also provides anatomical tracks favouring tumour cell dissemination, leading to model formulations that explicitly consider the larger cell motility in white matter compared with grey matter (Swanson et al 2000) , as well as differences in the mechanical resistance between both tissues. In the 3D model developed by Frieboes et al (2007) , brain structural properties play a critical role in the formation of rapidly developing tumour buds. Tumour buds invading the white matter encounter less mechanical resistance, leading to the formation of relatively slender invasive fingers, compared with the blunt bulbs invading the grey matter. The tumour buds rapidly elongate and grow along the folds of the cortex where the tumour cells are highly mobile. Interestingly, the overall tumour shape is also (Tracqui and Mendjeli 1999) . Data points correspond to the tumour volume measured from patient scans at the time of diagnosis and in course of therapy (black rectangles along the time axis). In each case, the left part of the curves, i.e. from the time of diagnosis back to the appearance of the first cancer cell, has been obtained by reversing time in the simulations, thus giving access to a predictive description of the silent (non-observable) phase of tumour growth.
determined by the distribution of vessels within the tumour, with the considered multiscale model providing simulations of growing glioma and neovascular morphologies that reflect histopathology data. The severity and poor prognosis of brain cancers is associated with a still limited understanding of the large diversity of the kinetics and growth patterns exhibited by the different types of brain tumours. Thus gliomas, highly invasive primary brain tumours accounting for almost 50% of all brain tumours, are known to grow at a wide range of possible proliferation and diffusion rates (Alvord 1995) . This stimulates modelling approaches trying to integrate in a single description tumour growth before and after diagnosis and therapy. Indeed, once detected, tumours are not left untreated in humans, and the imaged tumour growth results from the combined effect of initial endogenous tumour development and its response to therapy. The ability to distinguish between these two components of tumour growth is clearly a modelling challenge, especially when considering that therapy is not only translated into an additional cell death rate, but also modifies intrinsic tumour growth, for example by inducing mutations and emergence of new, usually therapy resistant, mutated subpopulations of cancer cells (Tracqui et al 1995) . Since the time of onset of the brain tumour is not known and thus the duration of the pre-diagnosis tumour growth is not clinically measurable, model simulation starts from a more or less well-defined initial tumour morphology, which determines a subsequent growth pattern against which the clinical data extracted from the analysis of serial scans may be compared. However, if assuming as a first simplification that the endogenous tumour dynamical features remain unchanged after therapy, modelling tumour growth pattern after diagnosis interestingly provides a basis for reconstructing pre-diagnosis tumour morphology and associated tumour growth history. Indeed, by reversing time in model simulation starting from diagnosis, it becomes possible to track back the temporal pattern of the glioblastoma development up to the appearance of the first cancer cell (figure 13). Such estimations may be used as a quantitative basis to define a range of patient ages where early detection of primary tumour can be planed.
An additional benefit of brain tumour growth models is their ability to evaluate virtually, but on quantitative bases, the comparative effects of different and independent or more often combined therapies, in a patient-dedicated way. Special attention has been paid to post-surgical behaviour of gliomas after resection through in silico experiments conducted with virtual gliomas (Swanson et al 2003 , 2008a , Woodward et al 1996 . Even if the resection seems optimal from a surgical point of view, i.e. presumably removes almost all the cancer cells, it is indeed well known that the small number of cells left behind could be sufficient for inducing a complete re-appearance of the tumour some months later. The recurrence of the tumour can start from the tumour cells left behind, and this minority of surviving tumour cells is aggressive enough to drastically reduce patient life expectancy (figure 14) (Swanson et al 2008a, Tracqui and Mendjeli 1999) . Similarly, Alvord and colleagues investigated the response to radiation therapy, focusing on the effect of radiation dose fractionation on gliomas growth (Rockne et al 2009 , Swanson et al 2008b . Thus, simple biophysical models, specified by a very limited number of parameters, allow a coherent qualitative and quantitative description of the wide spectrum of gliomas growth and invasiveness patterns. Moreover, their ability to predict quite successfully many aspects of real gliomas growth favours their systematic use as tumour grading tools enabling a dynamic identification of biologically distinct groups of gliomas.
Biophysical models of brain tumours can also support investigation of rather different therapeutic strategies. Cristini et al (2005) analysed targeting of brain tumours by anti-angiogenic therapy.
Whereas it seems clear that a direct action against tumour growth was to reduce angiogenesis, the modelling approach they developed suggests that such intuitive consideration has to be modulated by more subtle considerations. Indeed, a properly working tumour microvasculature can help maintain compact noninfiltrating tumour morphologies by minimizing oxygen and nutrient gradients. In contrast, anti-angiogenic therapy, by increasing microenvironmental heterogeneity, may promote morphological instability, leading to invasive patterns even under conditions in which the overall tumour mass shrinks. The model of Cristini et al (2005) suggests that antiangiogenesis solely with an end to eradicating a tumour may not be the most prudent course. These conclusions modify the conventional view on angiogenesis leading to invasion and metastasis: a well-vascularized tumour may be morphologically stable due to homogeneous distribution of oxygen and nutrient supply, while local hypoxia or lack of cell nutrients due to inefficient neovasculature leads to regions of heterogeneous cell proliferation and migration, which, in turn, promotes an invasive tumour morphology . The model proposed by Welter et al (2008) , implementing a dynamically evolving vessels network within a growing tumour, also pointed out unexpected results: collapse and vessel regression did not decrease drug delivery to the tumours in their computations, a result implying that this mechanism would not be the major reason for diminishing drug delivery in real tumours.
Taken together, these different results highlight the ability of models in providing predictive guidelines for therapeutic strategies that, solely or in combination, and in the light of accurate estimations of expectable survival times, are geared toward optimization of patient-dedicated therapy.
Conclusions and perspectives
It is now becoming evident that modelling tumour growth is much more complex than it was thought not so long ago. Earliest approaches tended to consider that models, developed with regard to the multicellular spheroid paradigm, already address some key issues on cell proliferation and death controlled by availability of diffusible nutrients, with progressive development of necrosis in solid tumours. It turns out that it is not that simple, as stressed by Mueller-Klieser (2000) : the onset of necrosis is not caused by simply one factor, such as hypoxia, as it had been widely accepted for many years, and the development of necrosis in tumour spheroids is a complex phenomenon involving other factors, such as cell-cell and cell-matrix interactions, expression of growth factor receptors and adhesion molecules, etc. Thus, even if more detailed models of MTSph are still actively developed invoking diffusion-limited phenomena, other recent models explore alternative views, allowing necrotic regions to develop under conditions of adverse mechanical stress rather than in regions of low nutrient concentrations (Landman and Please 2001) . In parallel, tumour spheroids models can be revisited and improved for mimicking tumour stroma and vasculature (Alajati et al 2008 , Lin and Chang 2008 , Mueller-Klieser 2000 .
We highlighted in this review how a transition toward a more mature approach of solid tumour modelling has been taken this last decade, especially with the increasing consideration of biophysical factors in the control exerted by the tumour microenvironment onto the growth process. Indeed, the microenvironment is no longer modelled only as a provider of diffusible nutrients and growth factors, or as a medium in which inflammatory and immune processes take place, but as a deformable and remodelled tissue, with timevarying structural and mechanical properties which participate to the 'selective pressure' imposed to cell dynamics during tumour development.
This transition is correlated with the increasing development, in this post-genome sequencing era, of two research domains at the interface between physics, mathematics and cell biology. The first one is the recognized limitation of the reductionist approach, which, despite outstanding progresses made in normal and cancer cells molecular biology, is inadequate when used alone to capture the complexity of tumour progression and the onset of metastasis (Bizzarri et al 2008) . In addition, the overwhelming amount of data collected by molecular biology techniques has highlighted the need for a systemic approach of cellular and tissular biology. In this system biology framework, the tumour microenvironment is now a crucial element of the cancer puzzle. Thus, models of tumour growth are no longer limited to an inside transformation in cellular organization, resulting from mutations and controlled by external supply, but more globally as an altered signalling context in which dramatic modifications of the signalling-regulatory pathways originating from the tumour stroma and surrounding host tissue may markedly affect the structure, functioning and growth of the tumour Radisky 2001, Bissell et al 2005) .
These considerations introduce a second facet of the system biology of tumour growth, namely the increasingly recognized and documented importance of the biomechanical contexts as determinants of the cell signalling pathways. Notably, mechanotransduction processes profoundly influence all aspects of normal and cancer cells behaviour, including proliferation apoptosis, adhesion, migration, secretion, etc Ingber 2005, Ingber 2002 ). These elements highlight the need for tumour models development considering the superimposition of both biochemical and biomechanical regulatory pathways.
In this context, relevant representations of cell, tumours and host tissues as mechanical entities are necessary for the evaluation of stress and strains experienced and transmitted by the tumour cells. We illustrated in section 4 the diversity of models used to describe tumour mechanical properties, with tumours visualized as amorphous solids, viscous fluids or granular solid (Guiot et al 2007a) . Central to an understanding of tissue stress evolution is also the necessity of identifying the precise constitutive nature of growing tumour tissues, taking into account tumour heterogeneity. Different modelling choice can be made, either trying to define a homogenized continuum, or taking into account specifically tumour heterogeneity, anisotropy and multiphasic nature.
As reviewed here, such biomechanical models already help to increase our understanding of necrosis formation in tumour and MTSph development. But improved mechanical models of tumours and cancerous tissue also give qualitative and quantitative insights into the regulation of cell adhesion and migration. This includes both the subcellular levels, in terms of stress transmitted by the cells and controlling cell adhesion, as well as the cellular level, where we underlined how haptotaxis can be a key determinant of tumour cell migration, controlled by both the gradients of adhesion molecules and gradients of rigidity created within the surrounding matrix by proteases activity and ECM biosynthesis. We additionally highlighted that accurate modelling of tumours mechanical properties has a profound impact on our understanding of tumour vascularization and on the collapse of tumour blood vessels, which is of fundamental importance for the administration of anticancer agents.
In a broader modelling perspective, considering the superimposition, at different scales, of both biochemical and biomechanical regulatory pathways enforces the consideration of a tumour as a complex biological system governed intrinsically by nonlinear processes. The potential existence of multiple asymptotic solutions exhibited by nonlinear systems indicate that the development path of a tumour is not unique for a given set of genomic parameters, but depends on the initial condition and environmental perturbations experienced by the growing tumour.
We reviewed in this paper another systemic property of several tumour models, namely the emergence of specific instability modes in the spatial distribution of cancer cells at the tumour surface and its interpretation as a bifurcation process sustained by intrinsic instabilities. Such a bifurcation scenario is clearly very helpful to predict whether a particular tumour type in a given host tissue would exhibit at some developmental stage a transition from a compact shape with smooth margins toward a stellate morphology with fingering or filopodial extensions, the latter being the signature of an invasive phenotype. The problem is that a rather large spectrum of instability mechanisms can trigger the onset of fingerlike invasive patterns. Existing models mostly considered diffusive instabilities, either as a simple Turing-like prepatterning of the tumour surface alone , or alternatively nonlinear interactions and development of cellular forces at the tumour-host tissue interface. In these models, the irregular tumour morphology results from a global and synchronized patterning of the tumour surface, but one may ask whether the invasive branching rather results from a desynchronized activity that takes place at different sites across the tumour surface. This pleads for a refined modelling of microenvironment influence on transition toward invasive types of tumour morphologies. It is known that hypoxia or nutrient deprivation leads to invasive tumour behaviour, but the work of Anderson et al (2006) additionally showed that alterations of the microenvironment, from homogeneous to inhomogeneous structure, could produce a change from smooth, non-invasive margins, to morphologically invasive, fingering margins.
Such requirements for refined biophysical models of tumour growth feedbacks onto the integrative modelling strategy quoted in the introductory part of this section, which tends to consider cancer as a systemic disease and more specifically to provide an all-comprehensive model of tumour growth (Anderson and Quaranta 2008) . A clear implication of this perspective is to address the fundamental problem of coupling different phenomena at different scales, attempting to integrate detailed subcellular information to make predictions at the tumour scale. Filling the gap between microscopic and macroscopic descriptions is a challenge of fundamental importance for tumour growth modelling, which leaves an open space for the development of models that has just begun to be explored (Ingber 2008b) . One may think to a juxtaposition of models or to intermediate, so-called mesoscopic models (Anderson and Quaranta 2008) in order to present a unified and integrative model of the entire process of tumour development. In this system biology framework, most promising models are likely to be based on hybrid continuous-discrete descriptions and formalisms. Indeed, continuum descriptions of tumour growth are supported by the existing bodies of phenomenological and constitutive laws elaborated in agreement with fundamental physical principles, and thus take benefit from the knowledge gained in other fields of physics. This aspect has been especially emphasized in the above sections with the various approaches proposed to describe a solid tumour in the framework of continuum mechanics, with tumour description based on analogies with fluid dynamics or well-known mechanisms of fracture mechanics (Guiot et al 2006 (Guiot et al , 2007b . Additionally, the spatio-temporal evolution of the associated vector fields is also partly amenable to theoretical analysis, with emerging simulated behaviours of the models controlled by a rather limited number of parameters or parameter groupings, as illustrated with diffusion-instabilities predictions. Thus, Guiot et al (2007a) defined an invasion parameter (IP) through a formula that identifies the most relevant physical parameters, e.g. the tumour's surface tension, its radius and the confining host tissue pressure, whose control should be the target of dedicated therapies. Eventually, a cancer type, organ site and patient-specific IP may be of significant value for diagnostic purposes, as most of this multicellular behaviour occurs well below the current non-invasive imaging resolution limits. In the same perspective, Chaplain and Sleeman (1993) originally proposed earlier a classification and grading of solid tumours based on strain energy functions. However, we are still looking for appropriate constitutive laws for modelling tumours mechanical properties, knowing that these laws may change with tumour types and grading.
Despite these advantages, the averaging over space realized in continuum formalisms can hardly account for the diversity of cellular and subcellular dynamical features and genetic or epigenetic regulatory mechanisms exhibited at the individual cell level. Alternatively, discrete models are perfectly adapted for modelling internal signalling networks within each cell. Thus, hybrid models, in which individual cells are treated discretely but interact with other chemical and mechanical continuum fields, are likely to combine the benefits of both descriptions. Under appropriated formalisms, such models will be able to couple the different spatial scales impacted by the growth process with biochemical and biomechanical information passed between multiple scales. Especially, these multiscale biophysical models should help to understand how the emerging shift of architectural and tensional homeostasis of the host tissue is shifted toward malignancy by bifurcation processes taking place within interactive complex signalling networks. In addition to the diffusive or mechanochemical instabilities quoted here, these modelling approaches will put into a broader perspective and larger basis the consideration of tumour branching and invasiveness as instability phenomena.
Nevertheless, this is clearly an enormous challenge when considering the increasing number of components to consider within the 'omics family' which characterize complex functions of many cellular components. In addition to genomics, transcriptomics and proteomics (Doucet and Overall 2008) , metabolomics has been added more recently, as the discipline that describes 'the complete set of metabolites/low-molecular-weight intermediates, i.e. the metabolome, that vary according to the developmental or pathological state of the cell, tissue, organ or organism' (Nielsen and Oliver 2005) . Similarly, let us add by analogy mechanomics as the discipline analysing the variation of the complete set of mechanical interactions at the cell-ECM interface, i.e. the mechanome, in a context dependent way.
The point is that, to increase their relevance, biophysical models of tumours should tell us something about how genome, transcriptome, proteome, metabolome and mechanome networks and charts evolve with variation of physical fields defining macroscopically the environmental context. However, such multiscale models are likely to become more and more complicated, with large increase in the model parameters. Then, a risk is that they may succeed in supporting partly intuition through computational results, but without giving real understanding and insight into underlying biological principles, and without ensuring to get relevant predictions and exploration of all possible model behaviours.
A guard against building over complicated models might be to keep a functional view of tumorigenesis and malignancy, as a drift from a morphofunctional field, defined as the physiological spatio-temporal coherence and regulation of cells and tissues organization. This view is closely connected to the earlier concept of epigenetic landscape introduced by C H Waddington to deal with cell fate in embryogenesis and morphogenesis (Waddington 1968) . Thus, the appearance of a tumour indicates a breakdown of this morphofunctional field, the organizing properties of the tissue homeostasis being gradually lost as the tumour develops. Within this framework, tumorigenesis is no longer studied as a merely deterministic consequence of altered gene function, but rather as an emerging response of network-structured interactions. For nonlinear systems, these interactions would define the number and topologies of each attraction bassin of the phase portrait associated to the considered model Ingber 2006, Huang et al 2005) . The dynamic of the model variables in response to the different environmental and endogenous stimuli experienced by the tumour cells may correspond to transitions between attraction basins (domains), i.e. to the crossing of the boundaries (or barriers) that delineate each of them. In this spirit, Gatenby and Gillies (2008) recently developed the concept of adaptive landscape to qualify the microenvironmental forces and selection mechanisms acting at work on tumour cells population during carcinogenesis. Considering that the tumour stroma is modified at critical steps during cancer development, they analyse the sequence of multiple and self-interacting proliferation barriers that are overcome in carcinogenesis, emphasizing that multiple strategies may be used to overcome a tissue barrier to proliferation, while adaptation to one barrier may decrease or increase the height of subsequent barriers. In this perspective, relevance and explanatory power of biophysical models of tumorigenesis might be evaluated through their capacity to include one adaptation to every barrier, while exploring different strategies serving as adaptations to the considered barrier. At the same time, the breakdown of the normal morphofunctional field becomes predominantly explainable from the analysis of the processes and functions ensuring the adaptation to the barrier (e.g. adhesion or proteolysis), rather than from the detailed knowledge of the biological actors coming into play (e.g. the precise integrin or metaloprotease at work).
In conclusion, the complexity of the system biology of cancer, even restricted to the development of solid tumours, still overwhelms us, leaving a huge gap between the enormous amount of experimental information that has been collected, and the explicative and predictive power of theoretical models.
But even if open problems in the study of tumour development are still numerous, biophysics models have still a lot to offer to improve our understanding of tumour morphodynamics. We outlined the different ways recent models provide mechanistic insights on tumour growth and vascularization through quantitative simulations that determine how combinations of microenvironmental and cellular parameters trigger invasive tumour morphologies. Consideration of the many possible feedback loops, either autobaric or parabaric, which regulate biomechanical interactions between normal and cancer cells and the tumour extracellular environment is still largely lacking, but analysing how mechanical stresses acting onto cell secretory activity come into play through mechanotransduction processes is a promising orientation for new integrative models (Butcher et al 2009, Macklin and . A longterm goal of the modelling effort is the ability to predict which combination of the key functional switches (proliferation, death, degradation, biosynthesis, migration, traction, etc) might reverse the invasive behaviour of individual and specific tumours, based on actual measurements of molecular, cellular and microenvironmental parameters (Ingber 2008a) . A more accessible, short-term goal, of the modelling effort, enhanced by the percolation of biophysical models in biology and medicine, is to actively participate to the design of new experimental models. Progress in tissue engineering is encouraging for the larger development of assays targeting tumour-stroma interactions, interactions between tumour and immune cells and tumour vascularization , Ingber 2008a ). Another short-term goal for biophysical models development, with strong implications in health care, is their use as predictive tools in drug discovery and in the management of cancer patients. In addition to molecular or biochemical studies focusing on cell sensitivity and chemoresistance, they will contribute to explain from a more systemic and virtual approach why some therapies fail while others prove to be effective in locally controlling tumour expansion. Models already appeared as efficient tools for gathering the information on tumour morphology, biology and metabolism in conjunction with multimodal high-resolution imaging techniques. As an adjunctive aid to customize therapy in individual patients, such practical successes will be highly encouraging, since even if an increasing effort is being made for the understanding complexity of tumorigenesis, elaborating new modelling paradigms that integrate all available knowledge remains a challenge facing us. 
